Medicsight has entered a preliminary agreement with Toshiba Medical System’s System Integration division for the resale of its MedicRead Colon and ColonCAD software solutions throughout Japan.

Under the terms of the agreement, Toshiba will work with Medicsight to obtain MHLW approval in Japan, according to both companies.

“This agreement is timely as the recently announced positive outcomes of two major clinical trials are widely expected to accelerate the adoption of CTC (also known as virtual colonoscopy) as routine primary screening for colorectal cancer,” said David Sumner, CEO, Medicsight.